Appetite Suppressant Singapore: A Complete Women-Focused Guide from Dame

If you’re searching for an appetite suppressant in Singapore, you’re not alone. Medical weight management has advanced rapidly, and women now have more effective, safer options than ever – from short-acting oral suppressants to powerful weekly injectables that regulate appetite and fullness. 

As a women’s health telemedicine clinic, Dame prescribes evidence-based weight loss treatment with structured follow-up, so you get results without compromising safety. This guide explains how each option works, who it’s for, and how we tailor care to your weight loss goals and medical history.

What counts as an appetite suppressant?

Broadly, appetite suppressants reduce hunger signals, slow gastric emptying, and/or help you feel full sooner and longer, making calorie control easier. In Singapore, these are prescription therapies and must be used under medical supervision. Lifestyle coaching remains essential, but weight loss medication can meaningfully improve outcomes when you meet criteria (e.g. BMI thresholds or weight-related health conditions).

Fast facts: your options at Dame 

• Panbesy (phentermine HCl) – short-acting oral medication taken in the morning; quick onset suited to daytime appetite control.
• Duromine (phentermine resin) – long-acting, modified-release capsule designed to last through the day.
• Xenical (orlistat) – blocks dietary fat absorption in the gut; not a central appetite suppressant but reduces overall calorie uptake.
• Contrave (bupropion/naltrexone) – targets brain reward pathways to cut cravings.
• Saxenda (liraglutide) – daily GLP-1 weight loss injection that increases satiety.
• Wegovy (semaglutide) – weekly GLP-1 with robust weight-loss evidence and HSA approval.
• Mounjaro (tirzepatide) – weekly dual GIP/GLP-1; now HSA-approved in Singapore, including an indication for adult weight management (see criteria below).

Panbesy vs Duromine: short-acting vs long-acting phentermine

Phentermine has decades of clinical use as a short-term appetite suppressant. The formulation is what differentiates Panbesy and Duromine:

• Panbesy contains phentermine hydrochloride in an immediate-release form; peak levels typically occur around 3-4 hours; so it’s taken in the morning and avoided near bedtime to reduce insomnia.
• Duromine contains phentermine as an ion-exchange resin complex (modified release), designed to release gradually and last through the day.

Who it suits: Women looking for a short-term kick-start or daytime appetite control, especially when an oral option is preferred. We review blood pressure, sleep, and mood history before prescribing.

Common considerations: jitteriness, dry mouth, insomnia (especially if taken later in the day), and rare cardiovascular risks. Phentermine-containing weight loss medicine are generally intended for short-term use alongside a calorie deficit diet and activity plan. 

Xenical (orlistat): fat-absorption blocker

Xenical inhibits pancreatic lipases, reducing fat absorption by ~30% from meals. It doesn’t act centrally on appetite but can lower total calorie intake. It’s useful if you prefer to avoid stimulant-class medications. To minimise oily stools or urgency, we coach on low-fat meal planning and fat-soluble vitamin intake. 

Contrave (bupropion/naltrexone): craving control

Contrave works on the hypothalamic and mesolimbic pathways (hunger and reward), helping reduce emotional eating and late-night snacking. It’s typically titrated over 4 weeks. We carefully screen migraine history, seizure risk, and drug interactions to determine suitability.

GLP-1s for women: Saxenda & Wegovy

GLP-1 receptor agonists increase satiety, slow gastric emptying, and help regulate metabolism.

• Saxenda (liraglutide) – daily weight loss injection; clinically meaningful weight loss when paired with lifestyle changes.
• Wegovy (semaglutide) – weekly injection; in the STEP-1 trial, semaglutide 2.4 mg produced substantial, sustained weight loss versus lifestyle alone.

We titrate doses to reduce transient nausea or GI upset and provide nutrition guidance to maintain protein intake and lean mass.

Mounjaro (tirzepatide): now available in Singapore

Mounjaro is a dual GIP/GLP-1 receptor agonist given once weekly. In large trials (SURMOUNT-1), it achieved up to 21% average weight loss at higher doses over 72 weeks in adults without diabetes. Many women also report better control of cravings and portions as titration progresses. 

Regulatory status (Singapore): Mounjaro (tirzepatide) KwikPen is approved in Singapore for type 2 diabetes and for adult weight management, as an adjunct to reduced-calorie diet and increased physical activity in adults with BMI (body mass index) ≥ 30 kg/m2, or BMI ≥ 27 kg/m2 with at least one weight-related comorbidity (e.g. high blood pressure, dyslipidemia, OSA, heart disease, prediabetes, or T2D). It is prescription-only.

Which appetite suppressant is right for me?

At Dame, we match the treatment to your weight loss goals, timelines, medical history, and preferences:

• Need fast daytime appetite control or a short programme?
  Panbesy (short-acting) or Duromine (long-acting) can help curb hunger during active “reset” phases.
• Prefer to avoid stimulants or focus on meal composition?
  Xenical supports lower calorie absorption from fat.
• Struggle with cravings or emotional eating?
  Contrave targets reward-driven urges.
• Seeking the strongest evidence for meaningful, sustained loss with metabolism benefits?
  Wegovy (GLP-1) and Mounjaro (dual GIP/GLP-1) are leading options with robust trial data.

Read about practical strategies and medical weight loss solutions for women in Singapore here.

Safety, monitoring & realistic results

All prescription appetite suppressants require medical screening and follow-up. We monitor blood pressure/heart rate (for phentermine), GI tolerance (for GLP-1s/orlistat), mood, and nutrition (protein, fibre, hydration). For GLP-1/GIP-GLP-1 therapies, we start low and titrate to minimise nausea and implement high-protein meals to preserve lean mass. In landmark studies, semaglutide 2.4 mg and tirzepatide produced substantial average weight reductions when combined with lifestyle changes; individual results vary, and continued healthy habits are key to maintenance.

FAQs: Appetite suppressant Singapore

Is Mounjaro actually available here now?

Yes. Mounjaro (tirzepatide) KwikPen is HSA-approved in Singapore and available by prescription, including an indication for adult weight management under specific BMI criteria.

Is Wegovy approved in Singapore?

Yes. Wegovy (semaglutide) received HSA approval in 2023 and is available by prescription.

What’s the difference between Panbesy and Duromine?

Panbesy is short-acting (immediate-release phentermine HCl; peak ~3-4 hours).

Duromine is long-acting (modified-release phentermine resin) designed to last all day.

Which option leads to the most weight loss on average?

Injectables have the strongest data: Wegovy and Mounjaro produced substantial average losses in trials when combined with lifestyle changes. Choice still depends on our health profile and preferences.

Do I need a prescription in Singapore?

Yes. All medicines above are prescription-only and should be used with clinician guidance and follow-up.

Ready to start?

If you’re exploring appetite suppressants in Singapore, Dame offers women-centred, doctor-guided care with medications including Panbesy, Duromine, Xenical (orlistat), Contrave, Saxenda, Wegovy, and Mounjaro. Book a teleconsult to map your best path – safely, effectively, and on your terms.